Alvotech (ALVO)
13.96
+0.08
(+0.58%)
USD |
NASDAQ |
Jun 03, 16:00
13.94
-0.02
(-0.14%)
After-Hours: 20:00
Alvotech Cash from Investing (TTM): -35.94M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -35.94M |
December 31, 2023 | -46.34M |
September 30, 2023 | -46.35M |
Date | Value |
---|---|
June 30, 2023 | -47.26M |
March 31, 2023 | -64.22M |
December 31, 2022 | -63.54M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-64.22M
Minimum
Mar 2023
-35.94M
Maximum
Mar 2024
-50.61M
Average
-46.80M
Median
Cash from Investing (TTM) Benchmarks
AbbVie Inc | -11.10B |
Moolec Science SA | -2.224M |
Teva Pharmaceutical Industries Ltd | 931.00M |
Procaps Group SA | -28.66M |
NeuroMetrix Inc | 2.132M |